文献速递遗传性与小管间质肾病

脂质运载蛋白-2在ADTKD-UMOD中由尿调节素聚集诱导但不影响疾病进展

Lipocalin-2 Is Induced by Uromodulin Aggregates without Affecting Kidney Disease Progression in Autosomal Dominant Tubulointerstitial Kidney Disease- UMOD.
PubMed 文献 · J Am Soc Nephrol · 2026-03-26

该研究在Umod敲入小鼠模型、患者尿液及表达突变UMOD的mIMCD3细胞中探究LCN2在ADTKD-UMOD中的作用。结果显示LCN2诱导与UMOD聚集及内质网应激相关,遗传缺失Lcn2减少肾脏铁沉积但未改变UMOD积累、间质炎症或纤维化。结论提示LCN2是毒性蛋白病的生物标志物而非治疗靶点。

要点

  • LCN2上调与小鼠和细胞模型中突变UMOD聚集及内质网应激平行。
  • 患者特定UMOD变异与尿LCN2升高相关。
  • 敲除Lcn2减少肾脏铁沉积但不影响疾病进展。

核心结论

  • LCN2由细胞内UMOD聚集和内质网应激诱导,影响铁处理但不驱动纤维化或炎症,支持其作为毒性蛋白病的生物标志物而非治疗靶点。

研究设计与样本

  • 研究使用Umod敲入小鼠模型(C171Y、R186S、C125R)、患者尿液样本及表达野生型或突变UMOD的mIMCD3细胞。
  • 通过免疫印迹、免疫染色和ELISA评估LCN2表达,用Torin1刺激自噬评估对LCN2诱导的影响。
  • 将UmodR186S/+小鼠与Lcn2-/-小鼠杂交以确定LCN2缺陷对疾病进展的影响。

主要发现

  • 在UmodR186S/+、UmodC125R/+和UmodC171Y/+小鼠的肾脏和尿液中观察到强烈的LCN2诱导,与厚升支细胞中UMOD聚集和内质网应激严重程度相关。
  • 在患者中,特定UMOD变异与尿LCN2升高相关。
  • 在表达突变UMOD(C170Y、R185S)的mIMCD3细胞中,Torin1处理减少聚集并减弱LCN2诱导。
  • 在UmodR186S/+小鼠中遗传删除Lcn2减少间质铁沉积,但未改变UMOD积累、间质炎症或纤维化。

临床怎么用

  • 尿LCN2可作为ADTKD-UMOD中毒性蛋白病的生物标志物,但不应作为治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Lipocalin-2 upregulation paralleled intracellular uromodulin aggregates in mouse and cellular models of autosomal dominant tubulointerstitial kidney disease because of pathogenic uromodulin. The induction of lipocalin-2 was triggered by mutant uromodulin accumulation and endoplasmic reticulum stress in tubular cells. Genetic loss of lipocalin-2 reduced iron deposits in the kidney but did not affect kidney damage, indicating that lipocalin-2 was not driving disease progression. BACKGROUND: Autosomal dominant tubulointerstitial kidney disease due to pathogenic UMOD variants (ADTKD- UMOD ) is a toxic proteinopathy caused by intracellular accumulation of mutant uromodulin (UMOD) and endoplasmic reticulum (ER) stress. Lipocalin-2 (LCN2) is an acute phase protein induced by ER stress with context-dependent roles in kidney injury. METHODS: To examine the role of LCN2 in ADTKD- UMOD , we used Umod knock-in mouse models (C171Y, R186S, C125R), urine samples from affected patients, and mIMCD3 cells expressing wild-type or mutant UMOD. LCN2 expression was assessed by immunoblotting, immunostaining, and ELISA. Autophagy was stimulated with Torin1 to evaluate effects on LCN2 induction. UmodR186S/+ mice were crossed with Lcn2-/- mice to determine the impact of LCN2 deficiency on disease progression. RESULTS: Robust LCN2 induction was observed in kidneys and urine of UmodR186S/+ , UmodC125R/+ , and UmodC171Y/+ mice, correlating with UMOD aggregates and ER stress severity in thick ascending limb cells. In patients, specific UMOD variants were associated with elevated urinary LCN2. In mIMCD3 cells expressing mutant UMOD (C170Y, R185S), treatment with Torin1 reduced aggregates and attenuated LCN2 induction. Genetic deletion of Lcn2 in UmodR186S/+ mice decreased interstitial iron deposition but did not alter UMOD accumulation, interstitial inflammation, or fibrosis. CONCLUSIONS: LCN2 was induced by intracellular UMOD aggregates and ER stress in various models of ADTKD- UMOD . Although it influenced iron handling, LCN2 did not drive fibrosis or inflammation, supporting a role as a biomarker of toxic proteinopathy rather than a therapeutic target.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Lake J, Mariniello M, Schiano G, et al. Lipocalin-2 Is Induced by Uromodulin Aggregates without Affecting Kidney Disease Progression in Autosomal Dominant Tubulointerstitial Kidney Disease- UMOD. J Am Soc Nephrol. 2026. PMID: 41885939. doi:10.1681/ASN.0000001077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。